LUNG NON-SMALL CELL CARCINOMA

This study tested a special smoking cessation program for people with head and neck or lung cancer. The program included counseling, medication, and nicotine replacement to help patients cut down or quit smoking. Researchers wanted to see if reducing smoking could also change the…

This study tested whether the immunotherapy drug pembrolizumab can prevent lung cancer in 45 people with early-stage non-small cell lung cancer or suspicious lung nodules. Participants received the drug and were monitored for tumor response and survival. The goal was to see if bo…

This early-phase trial tested a vaccine called CIMAvax-EGF in 20 people at high risk for lung cancer or survivors at risk of recurrence. The vaccine works by helping the body make antibodies against a protein (EGF) that can fuel cancer growth. Researchers measured immune response…

This study looked at 182 older adults with blood cancer or lung cancer to see if a special calculator could predict who would have severe side effects from chemotherapy. Researchers measured patients' fitness before and after treatment. The goal is to help doctors choose safer tr…

This study watched conversations between 37 lung cancer patients and their doctors to create a decision aid. The tool is meant to help patients who have had surgery decide whether to have additional treatment. The goal is to make sure patients feel heard and satisfied with their …